IMMUNOHISTOCHEMISTRY CEA CARCINOEMBRYONIC ANTIGEN Test
Test Name: IMMUNOHISTOCHEMISTRY CEA CARCINOEMBRYONIC ANTIGEN Test
Components: CEA (Carcinoembryonic Antigen)
Price: 410.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery: Sample Daily by 6 pm; Report Block: 5 days, Tissue Biopsy: 5 days, Tissue large complex: 7 days
Method: Immunohistochemistry
Test Type: Cancer
Doctor: Oncologist, Pathologist
Test Department: DNA Labs UAE
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
Immunohistochemistry CEA (Carcinoembryonic Antigen) test is a diagnostic tool used to detect the presence of CEA in tissue samples. CEA is a glycoprotein that is normally produced during fetal development but is also found in small amounts in healthy adults. However, elevated levels of CEA can indicate the presence of certain cancers, particularly colorectal, pancreatic, and lung cancers.
The immunohistochemistry CEA test involves staining tissue samples with specific antibodies that bind to CEA. If CEA is present in the tissue, it will bind to the antibodies, allowing for visualization and detection. This test can be performed on various types of tissue samples, including biopsies and surgical specimens.
The immunohistochemistry CEA test is commonly used in the diagnosis and monitoring of colorectal cancer. It can help determine the extent of tumor spread, assess the effectiveness of treatment, and detect any recurrence of the cancer. Additionally, it can be used to differentiate between primary and metastatic tumors.
It is important to note that while the immunohistochemistry CEA test is a valuable tool, it is not specific to cancer and can also be elevated in other conditions such as inflammatory bowel disease, liver disease, and smoking. Therefore, it is usually used in conjunction with other diagnostic tests and clinical evaluation to make a definitive diagnosis.
| Test Name | IMMUNOHISTOCHEMISTRY CEA CARCINOEMBRYONIC ANTIGEN Test |
|---|---|
| Components | |
| Price | 410.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details | Immunohistochemistry CEA (Carcinoembryonic Antigen) test is a diagnostic tool used to detect the presence of CEA in tissue samples. CEA is a glycoprotein that is normally produced during fetal development but is also found in small amounts in healthy adults. However, elevated levels of CEA can indicate the presence of certain cancers, particularly colorectal, pancreatic, and lung cancers. The immunohistochemistry CEA test involves staining tissue samples with specific antibodies that bind to CEA. If CEA is present in the tissue, it will bind to the antibodies, allowing for visualization and detection. This test can be performed on various types of tissue samples, including biopsies and surgical specimens. The immunohistochemistry CEA test is commonly used in the diagnosis and monitoring of colorectal cancer. It can help determine the extent of tumor spread, assess the effectiveness of treatment, and detect any recurrence of the cancer. Additionally, it can be used to differentiate between primary and metastatic tumors. It is important to note that while the immunohistochemistry CEA test is a valuable tool, it is not specific to cancer and can also be elevated in other conditions such as inflammatory bowel disease, liver disease, and smoking. Therefore, it is usually used in conjunction with other diagnostic tests and clinical evaluation to make a definitive diagnosis. |
